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Retinal lesions caused by eye diseases such as glaucoma and age-related macular degeneration can, over time, eliminate
stimulation of parts of the visual cortex. This could lead to degeneration of inactive cortical neuronal tissue, but this has not
been established in humans. Here, we used magnetic resonance imaging to assess the effects of prolonged sensory deprivation
in human visual cortex. High-resolution anatomical magnetic resonance images were obtained in subjects with foveal
(age-related macular degeneration) and peripheral (glaucoma) retinal lesions as well as age-matched controls. Comparison of
grey matter between patient and control groups revealed density reductions in the approximate retinal lesion projection zones in
visual cortex. This indicates that long-term cortical deprivation, due to retinal lesions acquired later in life, is associated with
retinotopic-speciﬁc neuronal degeneration of visual cortex. Such degeneration could interfere with therapeutic strategies such as
the future application of artiﬁcial retinal implants to overcome lesion-induced visual impairment.
Keywords: macular degeneration; glaucoma; visual ﬁeld; visual cortex; voxel-based morphometry; grey matter density
Abbreviations: AMD=age-related macular degeneration; dB=decibel; POAG=primary open-angle glaucoma; SPM99=Statistical
Parametric Mapping analysis program version of 1999; SPM5=Statistical Parametric Mapping analysis program version of 2005;
VBM=voxel-based morphometry
Introduction
Age-related macular degeneration (AMD) and glaucoma, eye
diseases associated with the occurrence of visual ﬁeld defects,
are the two leading causes of visual impairment in the developed
world (Resnikoff et al., 2004). AMD is caused by accumulated
waste products in the tissues underneath the macula that interfere
with retinal metabolism and lead to retinal atrophy (Holz et al.,
2004; Zarbin, 2004). The disease causes ﬁeld defects that are
located in or near the central visual ﬁeld. In glaucoma, progressive
retinal ganglion cell loss and optic nerve damage occurs, in most
cases induced by an elevated intra-ocular pressure (Fechtner
and Weinreb, 1994; Nickells, 1996). Visual ﬁeld deterioration
typically starts peripherally and progresses towards the fovea.
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(Dougherty et al., 2003; Horton and Hoyt, 1991), when ﬁeld
defects occur in both eyes and overlap, the corresponding part
of visual cortex is no longer stimulated. An absence of stimulation
may result in changes in the cortical structure (Johansson, 2004;
Merzenich et al., 1984). This makes it relevant to ask whether
ﬁeld defects that have their origin at the level of the retina can
lead to deterioration in the structure of the occipital cortex.
Indeed, there is evidence that developmental visual disorders
such as amblyopia (Mendola et al., 2005) and albinism
(von dem Hagen et al., 2005) affect the structure of the human
occipital cortex. However, surprisingly little is known about the
consequence of visual deprivation later in life. A recent case
study showed degenerative changes in the visual cortex of a glau-
coma patient based on post-mortem examination (Gupta et al.,
2006). Previously, using magnetic resonance imaging (MRI),
Kitajima and colleagues had reported wider calcarine sulci in
a small group of patients with a variety of retinal pathology
indicating a possible link between visual ﬁeld defects and cortical
degeneration (Kitajima et al., 1997). In another study, compared
with healthy participants, subjects with normal-tension glaucoma,
but not those with primary open-angle glaucoma, showed more
pathological ﬁndings (ischemia) in sulci, ﬁssures, subarachnoid
spaces and ventricles (Acaroglu et al., 2001). However, the
status of the grey matter was not examined. Finally, using MRI,
in glaucoma patients a reduced size of the lateral geniculate nuclei
was reported (Gupta et al. 2009).
In the present article, we determined whether structural changes
in human visual cortex occur once disease of the eye has resulted
in an established homonymous visual ﬁeld defect. This question is
also relevant given conﬂicting reports on the presence of func-
tional occipital reorganization following retinal lesions (Baker
et al., 2005; Masuda et al., 2008; Smirnakis et al., 2005;
Sunness et al., 2004).
In the present study, visual ﬁeld measurements were used to
chart changes in visual sensitivity associated with the retinal visual
ﬁeld defects from AMD and glaucoma. MRI and subsequent
voxel-based morphometric analysis methods were used to selec-
tively assess the presence of any associated changes in grey matter
density in the two groups.
Materials and Methods
Subjects
Subjects with visual ﬁeld defects were recruited among the patient
population of the Department of Ophthalmology of the University
Medical Centre Groningen (Groningen, The Netherlands) and through
advertizements in magazines of patient associations. The group
consisted of nine patients suffering from AMD (two females and
seven males; mean age 73 years, range 51–82 years), and eight
patients with primary open-angle glaucoma (one female and seven
males; mean age 72 years, range 61–85 years).
AMD was deﬁned as the presence of a decreased visual acuity
in a patient with abnormalities in the macular area without any
other explanation. Abnormalities might be either drusen, hyper- or
de-pigmentation, geographic atrophy or signs of previous exudative
changes. A glaucoma patient was deﬁned as a patient with a repro-
ducible visual ﬁeld defect on conventional perimetry. The defects had
to be compatible with glaucoma and without other explanation. Optic
disc excavation had to be in line with glaucoma as well.
In addition, in both AMD and glaucoma groups, patients had to have
a homonymous scotoma of at least 10 degrees diameter in at least one
quadrant, for a minimum of 3 years. Patients with any other (neuro-)
ophthalmic disease that might affect the visual ﬁeld were excluded.
Homonymous visual ﬁelds defect in both groups were located
centrally or paracentrally. In glaucoma, the visual ﬁeld defect generally
starts paracentrally, progresses peripherally and ﬁnally expands
towards central parts in the last stage of the disease. This difference
in location and severity of visual ﬁeld losses is reﬂected in the visual
acuity (logMAR; logarithmic minimum angle of resolution) and in the
mean deviation (MD) scores of both groups. LogMAR is a logarithmic
transformation of the more common clinically used decimal notation.
A logMAR value of 0 corresponds to a visual acuity of 1.0 in decimal
notation. More positive numbers indicate that the minimum angle
of resolution is larger, and thus corresponds to a lower visual acuity.
The MD is the weighted average decrease in visual ﬁeld sensitivity
relative to the norm for a particular age group. Negative values
indicate a reduced sensitivity. Table 1 lists these characteristics.
For the control group, 12 healthy age-matched subjects (three
females and nine males; mean age 66 years, range 60–82 years)
were recruited. They were recruited from among the partners of the
visual ﬁeld impaired participants or via advertisement in a local news-
paper. Control subjects were required to have good (or corrected to
good) visual acuity (logMAR40), not to have any visual ﬁeld defect
and to be free of any ophthalmic, neurologic or general health problem.
This study conformed to the tenets of the Declaration of Helsinki
and was approved by the medical review board of the University
Medical Center Groningen (Groningen, The Netherlands). All partici-
pants gave their informed written consent prior to participation.
Visual ﬁeld measurements
Visual ﬁelds were recorded using the Humphrey Field Analyser
(Carl Zeiss Meditec, Dublin, CA, USA) running the 30-2 program
SITA (Swedish Interactive Threshold Algorithm)-Fast, a standard
method for the examination of the 30 central visual ﬁeld. In this
type of measurement, the subject is facing a white illuminated
sphere, on which points of light with varying intensities are brieﬂy
ﬂashed. The subject has to ﬁxate a set of centrally positioned ﬁxation
points during the measurement. Stimuli are presented one by one on a
grid in the central 30 of the visual ﬁeld. Subjects respond when they
perceive the ﬂash. The sensitivity at each location in the visual ﬁeld
is determined by changing the intensity of the ﬂash on subsequent
presentations. Each eye is measured independently, one eye is covered
while the other is tested.
To assess the relationship between the reduction in visual ﬁeld
sensitivity and changes in cortical grey matter density, for each
group, mean sensitivity deviation maps were calculated. This was
done in two steps. First, for each subject, a combined visual ﬁeld
map was created by taking, at each position, the smallest sensitivity
deviation from the left and right eye’s monocular measurements.
Second, the combined maps from all subjects in a group were
averaged to yield an average binocular sensitivity deviation map.
Magnetic resonance imaging
High-resolution MRI was performed on a 3.0 Tesla Philips Intera
(Eindhoven, The Netherlands). A three-dimensional structural image
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sequence T1W/3D/TFE-2, 8 ﬂip angle, repetition time 8.70ms,
matrix size 256256, ﬁeld of view 230160180, yielding
160 slices and voxel size 111mm
3.
Voxel-based morphometric analysis
We performed voxel-based morphometry analysis (Ashburner and
Friston, 2000), which is part of the SPM5 (Statistical Parametric
Mapping) software (Wellcome Department Imaging Neuroscience,
London, UK; http://www.ﬁl.ion.ucl.ac.uk/spm). Voxel-based mor-
phometry statistically assesses local changes in grey matter density
between groups of anatomical scans.
The brain images were registered to the International Consortium
for Brain Mapping space template. Using the standard segmentation
protocol in SPM5, each voxel was classiﬁed into one of the three
different tissues: grey matter, white matter and cerebrospinal ﬂuid.
Non-brain voxels were excluded from the statistical analysis by
applying a brain mask. Finally, the images resulting from the segmen-
tation were smoothed with a Gaussian kernel of 10mm full-width at
half-maximum.
For the statistical analysis, two contrasts were deﬁned: the ﬁrst
comparing grey matter density in the AMD group and the control
group and the second comparing grey matter density in the glaucoma
group and the control group. Even though the participant groups
were age-matched, there were some slight differences in the age
distribution. The subjects’ ages were therefore added as a covariate
to the analysis as an additional measure to control for any potential
remaining effect of age.
Volume-of-interest-based analysis
In addition to the voxel-based morphometric analysis, an anatomical
volume-of-interest (VOI) analysis was performed. For this analysis, in
each individual participant, 21mm diameter sphere VOIs were deﬁned
at the location that corresponded to the approximate expected
anatomical position of the foveal and peripheral visual ﬁeld represen-
tations. In each hemisphere, posterior (at the occipital pole; foveal
projection zone) and anterior (10mm posterior to the junction of
parieto-occipital and calcarine sulci) VOIs were deﬁned in both the
superior and inferior banks of the calcarine sulcus. Mean grey matter
density values were extracted from each subject’s grey matter for each
VOI and averaged over groups. For each VOI, relative grey matter
densities were calculated for the AMD and glaucoma group by divid-
ing the mean grey matter values by those of the control group.
Analysis of variance was used to examine the interaction between
the factors group (AMD and glaucoma) and cortical location (posterior
and anterior).
Results
Binocular visual ﬁelds
Figure 1 shows the binocular sensitivity deviaton maps for six
representative subjects, three from each group. On the basis of
the individual maps, for each group a mean binocular sensitivity
deviaton map was calculated. These mean maps are shown in
Figures 2D and 3D.
Age-related macular degeneration
Figure 2D shows the mean visual ﬁeld sensitivity deviation map for
the AMD group. A reduction in sensitivity is evident centrally on
and near the location of the fovea (56dB). Figure 2A–C shows
the comparison of grey matter density in the AMD group
compared with controls superimposed on the mean anatomical
Table 1 Subject characteristics
Subject Group Age Visual acuity of the
right eye (logMAR)
Visual acuity of the
left eye (logMAR)
Visual ﬁeld sensitivity of
the right eye (MD; dB)
Visual ﬁeld sensitivity of
the left eye (MD; dB)
1 AMD 74 1.8 1.3 n/a 7.57
2 AMD 67 0.5 0.1 5.5 4.50
3 AMD 62 1.3 0.7 11.48 2.69
4 AMD 82 1.1 1.0 6.28 4.96
5 AMD 78 1.0 1.8 3.51 7.04
6 AMD 81 1.1 0.7 6.06 3.64
7 AMD 76 0.5 0.8 5.79 2.64
8 AMD 51 1.0 1.0 12.01 14.08
9 AMD 82 0.5 0.4 3.43 2.20
Mean AMD 72.6
10 POAG 66 0.1 0.1 25.08 22.96
11 POAG 69 0.1 0.1 27.20 13.82
12 POAG 85 0.0 1.0 8.80 24.59
13 POAG 80 0.2 0.1 5.23 16.15
14 POAG 64 l.p. 0.7 l.p. 14.45
15 POAG 61 0.05 0.05 11.62 3.67
16 POAG 74 0.0 0.1 23.28 18.27
17 POAG 79 0.1 0.15 6.36 13.41
Mean POAG 72.3
Characteristics of the two patient groups (AMD and glaucoma) were visual acuity for one or both eyes (expressed in logMAR), visual sensitivity (expressed as MD in dB)
and age. logMAR=logarithm of minimum angle of resolution; MD=mean deviation; dB=decibel; AMD=age-related macular degeneration; POAG=primary open-
angle glaucoma; l.p.=light perception; n/a=not available.
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reduced compared with the control group. This main reduction
in density is located near the occipital pole (primarily in the left
hemisphere), particularly around the posterior part of the calcarine
ﬁssure (P50.001).
Glaucoma
Figure 3D indicates that in the glaucoma group mean visual ﬁeld
sensitivity is markedly reduced in the periphery of the visual ﬁeld,
in both the upper and lower hemiﬁelds (58dB). Importantly, in
contrast to the AMD group, the sensitivity is relatively spared in
the macular region. Figure 3A–C shows the comparison of
grey matter density between the glaucoma and control groups.
The results indicate the presence of a bilateral reduction of grey
matter density on the medial aspect of the occipital lobe, at the
anterior half of the calcarine ﬁssures (P50.001).
Figure 4 shows the results of an additional volume-of-interest-
based analysis. For this analysis, on each participant’s brain, small
sphere VOIs were deﬁned that correspond to the approximate
anatomical projection zones of the fovea and peripheral visual
ﬁeld. For each participant group, average relative grey matter
density in the anterior and posterior VOIs is plotted. This analysis
conﬁrms the results of the voxel-based morphometric analysis. In
the AMD group, the relative grey matter density is more reduced
in the posterior than in the anterior region. The glaucoma group
shows exactly the opposite result. Relative grey matter density
is more reduced in the anterior than in the posterior region.
This interaction was statistically signiﬁcant (P50.01).
Figure 5 summarizes the main results of this study, and shows
the pattern of decrements in grey matter density in the glaucoma
and AMD groups, as well as their respective (thresholded) sensi-
tivity deviation maps. Retinotopically, the pattern of grey matter
reduction that we ﬁnd in our study correlates well with the pattern
of changes in visual ﬁeld sensitivity in both types of pathology. In
AMD, the reduction in visual ﬁeld sensitivity is most pronounced in
the foveal region (Fig. 5A). Corresponding with this, the focus of
grey matter reduction in this group is located near the posterior
pole of the occipital cortex (Fig. 5A). In glaucoma, the main reduc-
tions in visual ﬁeld sensitivity are located more peripherally
(Fig. 5B). Consistent with this, the focus of the grey matter reduc-
tion in this group is located more anterior in the occipital cortex
(Fig. 5A).
Discussion
The main ﬁnding of this study is that visual ﬁeld defects caused by
long-standing retinal pathology due to glaucoma and AMD are
associated with reductions in grey matter density in occipital
Figure 1 Individual binocular sensitivity deviation maps. Upper row shows maps for three representative subjects from the AMD
group, the lower row shows maps for three subjects with glaucoma. Subject numbers correspond to those in Table 1.
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groups, the location of the grey matter density reduction corre-
sponded with the approximate visual ﬁeld defect projections
in visual cortex. The more central scotoma of the AMD subjects
correlated with a reduction located more posteriorly in occipital
cortex, in correspondence with the location of the foveal repre-
sentation in visual cortex. The difference was more pronounced in
the left hemisphere. In agreement, the sensitivity deviation map
shows a macular defect that was more pronounced in the right
visual ﬁeld. The more peripherally located scotoma in the glau-
coma subjects correlated with a reduction of grey matter density
located more anterior in occipital cortex. This is in correspondence
with the location of the cortical representation of the peripheral
visual ﬁeld. Therefore, our results suggest that retinal visual ﬁeld
defects acquired later in life can lead to retinotopically speciﬁc
grey matter density reduction in the visual cortex.
An earlier report on this study (Boucard, 2006) found no
signiﬁcant difference in grey matter density between the AMD
and the control groups. The analysis carried out in this preliminary
report used SPM99 rather than SPM5. The difference in results
can be attributed to improvements in the segmentation process
where SPM5 reaches a more detailed segmentation than SPM99.
The segmentation process in SPM5 takes advantage of a spatial
normalization that does not rely on the simple relationship
between the intensities of two images. The segmentation is
achieved by warping tissue probability maps in order to overlay
them on to the image to segment. The obtained spatially normal-
ized tissue class images of each subjects are averaged and used as
prior probabilities for each voxel to belong to a particular tissue
class (Ashburner and Friston 2005). Since this procedure is more
reﬁned and accurate, we report here the results obtained with
SPM5. Nevertheless, we believe that discrepancies in results
originating from differences in analyses should be considered
serious issues.
Our present results indicate a good correspondence between
the locations of the mean scotoma and the cortical regions
showing a reduction in grey matter density. When examining
the results at a more detailed level, however, a number of factors
may contribute to uncertainty (and thus deviations) in the corre-
spondence. First, we rely on normalization of the brains of the
subjects. Normalization, particularly in occipital cortex, is delicate
due to anatomical variability. Second, there will be differences in
how the functional visual ﬁeld maps onto the anatomy. Third, we
show the grey matter density reductions on the mean anatomical
Figure 2 Analysis of subjects with AMD. (A–C) Sections of the brain showing regions of grey matter density reduction. Colours
indicate statistical signiﬁcance (t-values), with red indicating more signiﬁcant changes, and yellow/green indicating less signiﬁcant
changes (all changes are at least P50.001, uncorrected). (D) Mean visual ﬁeld sensitivity deviation (in dB). The largest change in
sensitivity is located centrally in the visual ﬁeld. dB=decibel.
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average anatomy is equal. Yet, the contribution to the group’s
focus on the density reduction is not necessarily equal for each
participant. Fourth, the extent of the cortical regions showing a
reduction varies with the statistical threshold used. Finally, it is not
a priori clear when (in terms of sensitivity deviation and diameter)
a retinal scotoma will result in a reduction of grey matter density.
We have here, for both the participant selection and analysis of
the visual ﬁeld, made the assumption that this is only in the case
of relatively large, homonimous scotoma. For this reason, we
computed the binocular maps for individual participants using
the minimum deviation in sensitivity and averaged these. Yet,
grey matter density reduction may occur for monocular defects
as well. A more extensive analysis including patients with different
(also monocular) ﬁeld defects would be required to indicate
precisely how the depth and extent of the retinal lesion is related
to changes in grey matter density and functional anatomy of the
visual cortex.
This study involved older participants, so the possibility that
the reported changes are simply due to ageing effects should be
considered. Salat et al. (2004) showed that cortical thinning due
to ageing might involve the primary visual cortex among other
cortical areas, although the correlation with age was only weak.
Raz et al. (2005) conﬁrmed that regional volume change due to
ageing in the visual cortex is very weak. To control for possible
ageing effects, we ensured that the groups were, on average, age-
matched. Our volume-of-interest-based analysis indicates a slight
overall reduction in grey matter density in both patient groups
compared with the control group, in addition to the speciﬁc
scotoma-related reductions. In the voxel-based comparisons of
cortical grey matter density we included age as a covariate to
remove any age-related residual inﬂuences. Hence, we are conﬁ-
dent that the present results are not merely due to age. The
generalized reduction in grey matter density observed in the
VOI-based analysis could be due to variability in the ﬁeld defects.
The defects in both patient groups, although primarily centrally
located for AMD and more peripherally for glaucoma patients,
do show some spreading between individual subjects (Fig. 1).
Grey matter density reduction related to ﬁeld defects that vary
between the individual members of a patient group could show
up as a generalized effect. Nevertheless, for each patient group
the location of the focus of the grey matter density reduction
clearly corresponds to the expected lesion projection zone of
mean visual ﬁeld defect (Figs. 2, 3 and 5).
Figure 3 Analysis of subjects with glaucoma. (A–C) Sections of the brain showing the regions of grey matter density reduction.
Colours indicate statistical signiﬁcance (t-values), with red indicating more signiﬁcant changes, and yellow/green indicating less
signiﬁcant changes (all changes are at least P50.001, uncorrected). (D) Mean visual ﬁeld sensitivity deviation (in dB). The largest
changes in sensitivity are located peripherally in the visual ﬁeld, leaving the macular region relatively unaffected. dB=decibel.
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relationship between acquired retinal visual ﬁeld loss and grey
matter degeneration in human visual cortex. An earlier MRI
study had suggested calcarine atrophy to be related to retinal
degeneration (Kitajima et al., 1997). However, the participants
in this study had not only widely varying retinal pathology but
also relatively coarse measures of degeneration (width of the
calcarine sulcus). Since no segmentation of grey and white
matter was performed, the ﬁndings may not be due to grey
matter degeneration. A post-mortem study reported to have
found a reduction of the cortical ribbon thickness in the visual
cortex in glaucoma. However, this study reported on anatomical
and histological examination of a single subject only (Gupta et al.,
2006).
In glaucoma, cortical degeneration can be interpreted as a result
of the loss of retinal ganglion cells. The atrophy from damaged
parts of the retina likely propagates by means of transneuronal
degeneration through the optic nerve towards the cortex, thereby
provoking its subsequent degeneration. Experimentally, this
sequence of events has been shown to occur in cats and monkeys
where the retina was experimentally injured by an induced
elevated intra-ocular pressure (Yucel et al., 2003).
In AMD, the relationship between retinal pathology and cortical
degeneration might be slightly more indirect, in that photoreceptor
damage may ﬁrst lead to retinal ganglion cell loss. It has been
shown that the retinal ganglion cell count is signiﬁcantly lower
in wet AMD than in otherwise healthy eyes (Medeiros and
Curcio, 2001). Eyes with geographic atrophy due to AMD also
have a lower count of retinal ganglion cells (Kim et al., 2002).
Figure 5 Summary of visual ﬁeld sensitivity and grey matter reduction in AMD and glaucoma. (A) Cortical grey matter density
reduction in glaucoma is found in the anterior half of the medial occipital cortex (cyan). Cortical grey matter density reduction in AMD
(magenta) is found in the posterior part of the occipital cortex. (B) Thresholded mean visual ﬁeld sensitivity deviation maps indicating
central defects in AMD (magenta) and more peripheral defects in glaucoma (cyan). For this thresholded map, for the glaucoma group,
sensitivity deviations below 12dB are shown in cyan. For the AMD group, sensitivity deviations below 8dB are shown in magenta.
Figure 4 Results from a VOI-based analysis. Relative change
in grey matter density for the AMD and glaucoma groups
compared to the control group in anatomically deﬁned volumes
of interest in posterior (approximate foveal projection zone)
and anterior (approximate peripheral visual ﬁeld projection
zone) visual cortex. Relative changes were calculated by
dividing for each participant group the averaged grey matter
density in each VOI by that of the control group.
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reduction in retinal ganglion cell count and optic nerve damage,
a voxel-based morphometry study reported abnormally reduced
grey matter volume at the occipital poles of a group of human
albinos (von dem Hagen et al., 2005). There is no direct evidence
demonstrating that retinal ganglion cell loss occurred in our
AMD group. However, a reduction in visual ﬁeld sensitivity is
linked to retinal ganglion cell loss and not to other components
of the neuro-retina (Garway-Heath et al., 2000; Swanson et al.,
2004). Moreover, foveal sensitivity is greatly reduced in AMD.
Together, this suggests the possibility that retinal ganglion cell
loss does occur in AMD-associated visual ﬁeld defects. This loss
could be responsible for the cortical degeneration we have
observed.
A number of studies have examined whether functional
reorganization accompanies retinal lesions. Thus far, reports have
presented conﬂicting results with some groups reporting an
absence of reorganization (Smirnakis et al., 2005; Sunness et al.,
2004) and others reporting its presence (Baker et al., 2005).
This difference in ﬁndings has recently been attributed to differ-
ences in stimuli and tasks used in the various studies (Masuda
et al., 2008). More cognitively engaging tasks appear to result
in feedback signals from later visual areas that also drive neuronal
activity in the lesion projection zones. Such feedback signals
appear absent in visually healthy subjects. While one could
argue that this indicates a form of functional reorganization, it
leaves open the question whether the lesion projection zone of
primary visual cortex is still able to process retinal signals. This
question is particularly relevant given the rapid developments in
retinal prostheses. Our study indicates a reduction in grey matter
in the approximate lesion projection zones of primary visual
cortex. Given that feedback signals still appear to be processed,
we speculate that the grey matter reduction reported on here
could be selective to the input layers of primary visual cortex.
In summary, this study shows that long-standing visual ﬁeld
defects due to retinal pathology are associated with retinotopic
speciﬁc grey matter reduction in early visual cortex. These ﬁndings
contribute to the understanding of brain plasticity at a later age.
From a clinical point of view, a better understanding of the
relation between retinal visual ﬁeld defects and structural changes
in visual cortex may help understand disease symptoms as well as
their progression. For instance, cortical degeneration may limit the
efﬁcacy of rehabilitation and training programmes (Safran and
Landis, 1996), retinal prostheses (Hossain et al., 2005) and may
require new therapeutic strategies (Gupta and Yucel, 2007; Taub
et al., 2002) to prevent blindness. Prevention of cortical degener-
ation associated with eye diseases may also need to become a
new therapeutic goal.
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